Cullings H M, Grant E J, Egbert S D, Watanabe T, Oda T, Nakamura F, Yamashita T, Fuchi H, Funamoto S, Marumo K, Sakata R, Kodama Y, Ozasa K, Kodama K
*Department of Statistics, Radiation Effects Research Foundation, Hijiyama Park 5-2, Minami-ku, Hiroshima 732-0815, Japan; †Department of Epidemiology, Radiation Effects Research Foundation, Hijiyama Park 5-2, Minami-ku, Hiroshima 732-0815, Japan; ‡LEIDOS Corporation, San Diego, CA; §Department of Information Technology, Radiation Effects Research Foundation, Hijiyama Park 5-2, Minami-ku, Hiroshima 732-0815, Japan; **Biosample Center, Radiation Effects Research Foundation, Hijiyama Park 5-2, Minami-ku, Hiroshima 732-0815, Japan; ††Radiation Effects Research Foundation, Hijiyama Park 5-2, Minami-ku, Hiroshima 732-0815, Japan.
Health Phys. 2017 Jan;112(1):56-97. doi: 10.1097/HP.0000000000000598.
Individual dose estimates calculated by Dosimetry System 2002 (DS02) for the Life Span Study (LSS) of atomic bomb survivors are based on input data that specify location and shielding at the time of the bombing (ATB). A multi-year effort to improve information on survivors' locations ATB has recently been completed, along with comprehensive improvements in their terrain shielding input data and several improvements to computational algorithms used in combination with DS02 at RERF. Improvements began with a thorough review and prioritization of original questionnaire data on location and shielding that were taken from survivors or their proxies in the period 1949-1963. Related source documents varied in level of detail, from relatively simple lists to carefully-constructed technical drawings of structural and other shielding and surrounding neighborhoods. Systematic errors were reduced in this work by restoring the original precision of map coordinates that had been truncated due to limitations in early data processing equipment and by correcting distortions in the old (WWII-era) maps originally used to specify survivors' positions, among other improvements. Distortion errors were corrected by aligning the old maps and neighborhood drawings to orthophotographic mosaics of the cities that were newly constructed from pre-bombing aerial photographs. Random errors that were reduced included simple transcription errors and mistakes in identifying survivors' locations on the old maps. Terrain shielding input data that had been originally estimated for limited groups of survivors using older methods and data sources were completely re-estimated for all survivors using new digital terrain elevation data. Improvements to algorithms included a fix to an error in the DS02 code for coupling house and terrain shielding, a correction for elevation at the survivor's location in calculating angles to the horizon used for terrain shielding input, an improved method for truncating high dose estimates to 4 Gy to reduce the effect of dose error, and improved methods for calculating averaged shielding transmission factors that are used to calculate doses for survivors without detailed shielding input data. Input data changes are summarized and described here in some detail, along with the resulting changes in dose estimates and a simple description of changes in risk estimates for solid cancer mortality. This and future RERF publications will refer to the new dose estimates described herein as "DS02R1 doses."
剂量测定系统2002(DS02)为原子弹爆炸幸存者寿命研究(LSS)计算的个人剂量估计值,是基于指定爆炸时(ATB)位置和屏蔽情况的输入数据得出的。最近,一项旨在改善幸存者爆炸时位置信息的多年努力已经完成,同时对其地形屏蔽输入数据进行了全面改进,并对辐射效应研究基金会(RERF)结合DS02使用的计算算法进行了多项改进。改进工作始于对1949 - 1963年期间从幸存者或其代理人处获取的关于位置和屏蔽的原始问卷数据进行全面审查和优先级排序。相关源文件的详细程度各不相同,从相对简单的列表到精心绘制的结构及其他屏蔽和周边街区的技术图纸。通过恢复因早期数据处理设备限制而被截断的地图坐标的原始精度,以及校正最初用于指定幸存者位置的旧(二战时期)地图中的变形等改进措施,减少了这项工作中的系统误差。通过将旧地图和街区图纸与根据轰炸前航空照片新构建的城市正射影像镶嵌图对齐来校正变形误差。减少的随机误差包括简单的转录错误以及在旧地图上识别幸存者位置时的错误。最初使用较旧方法和数据源为有限的幸存者群体估计的地形屏蔽输入数据,现在使用新的数字地形高程数据对所有幸存者进行了重新估计。算法改进包括修复DS02代码中耦合房屋和地形屏蔽的错误,校正计算地形屏蔽输入所用地平线角度时幸存者位置的海拔高度,改进将高剂量估计值截断至4 Gy以减少剂量误差影响的方法,以及改进计算平均屏蔽传输因子的方法,该因子用于在没有详细屏蔽输入数据的情况下计算幸存者的剂量。在此详细总结并描述了输入数据的变化,以及剂量估计值随之产生的变化,还有对实体癌死亡率风险估计值变化的简单描述。本报告以及辐射效应研究基金会未来的出版物将把此处描述的新剂量估计值称为“DS02R1剂量”。